Clinical trial

Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency

NCT02430753

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-01-01

PhaseNA

Study timeline

Study start (actual)2015-01-01Date precision: day

Registry last updated2021-09-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Neoplasms Accompanied by Respiratory Function Insufficiencyunresolved

Interventions

Irreversible electroporation (IRE)PROCEDURE

NanoKnifeDEVICE

Sponsors & collaborators

Fuda Cancer Hospital, Guangzhoulead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02430753 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.